Table 2.
Citation (PMID) |
Cohort and location* | Numbers of Ethnicity/Race(s) examined | Cohort size | Pathologies examined | Inclusion Criteria | Main findings |
---|---|---|---|---|---|---|
White L, …, Markesbery W. Ann N Y Acad Sci, 2002. (12480729) | HAAS, Oahu, HI |
|
285 |
☐ AD ☐ CVD ☐ LBD |
Came to autopsy between 1991 to 1999 |
|
Petrovitch H, …, White LR. Ann Neurol 2005. (15562458) | HAAS, Oahu, HI |
|
333 |
☐ AD ☐ CVD |
|
|
White L. J Alzheimers Dis. 2009. (19661625) | HAAS, Oahu, HI |
|
443 |
☐ AD ☐ CVD ☐ LBD |
Came to autopsy between 1992 to 2004 |
|
Launer LJ, …White LR Ann Neurol 2011. (22162060) |
HAAS, Oahu, HI |
|
436 |
☐ AD ☐ CVD |
Came to autopsy between 1992 and 2001 |
|
White LR, …, Montine TJ; Neurology, 2016. (26888993) | HAAS, Oahu, HI and the Nun Study (NS) from Montreal, Canada |
|
1,108 |
☐ AD ☐ CVD ☐ LBD |
|
|
Latimer CS, … Montine TJ. J Neuropathol Exp Neurol, 2017. (28499012) | HAAS, Oahu, HI and the Nun Study (NS) Montreal, Canada |
|
1,262 |
☐ AD ☐ CVD ☐ LBD |
Completed NIA-AA ABC scores |
|
All published studies within table included individuals from the Honolulu Asian Aging Study (HAAS) which is a continuation of the Honolulu Heart Program54. Persons within HAAS consisted of Japanese American men born between 1900 and 1920 living in Oahu during baseline examination in 1965. Participants were evaluated for dementia starting in 1991 (age 73 to 94 years), the autopsy program began in 1992. Abbreviations: AD=Alzheimer’s Disease, CVD=Cerebrovascular disease, Hpscl=Hippocampal Sclerosis, LBD=Lewy body disease, NP=neuritic plaques, NFT=Neurofibrillary Tangle